These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mutations induced at the hypoxanthine-guanine phosphoribosyltransferase locus of human T-lymphoblasts by perturbations of purine deoxyribonucleoside triphosphate pools. Mattano SS; Palella TD; Mitchell BS Cancer Res; 1990 Aug; 50(15):4566-71. PubMed ID: 2369732 [TBL] [Abstract][Full Text] [Related]
24. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia. Kurtzberg J; Hershfield MS Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167 [TBL] [Abstract][Full Text] [Related]
25. Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints. Leanza L; Miazzi C; Ferraro P; Reichard P; Bianchi V Exp Cell Res; 2010 Dec; 316(20):3443-53. PubMed ID: 20603113 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes. Scharenberg JG; Spaapen LJ; Rijkers GT; Wadman SK; Staal GE; Zegers BJ Adv Exp Med Biol; 1986; 195 Pt B():191-9. PubMed ID: 3094325 [No Abstract] [Full Text] [Related]
27. The effect of deoxyguanosine on human lymphocyte function. II. Analysis of the interference with B lymphocyte differentiation in vitro. Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Duran M; Stoop JW; Zegers BJ J Immunol; 1984 May; 132(5):2318-23. PubMed ID: 6425400 [TBL] [Abstract][Full Text] [Related]
28. Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates. Fletcher TM; Salazar M; Chen SF Biochemistry; 1996 Dec; 35(49):15611-7. PubMed ID: 8961922 [TBL] [Abstract][Full Text] [Related]
29. Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes--a novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies. Bantia S; Parker C; Upshaw R; Cunningham A; Kotian P; Kilpatrick JM; Morris P; Chand P; Babu YS Int Immunopharmacol; 2010 Jul; 10(7):784-90. PubMed ID: 20399911 [TBL] [Abstract][Full Text] [Related]
30. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine. Dahbo Y; Eriksson S Eur J Biochem; 1985 Aug; 150(3):429-34. PubMed ID: 3874778 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts. Kazmers IS; Mitchell BS; Dadonna PE; Wotring LL; Townsend LB; Kelley WN Science; 1981 Dec; 214(4525):1137-9. PubMed ID: 6795718 [TBL] [Abstract][Full Text] [Related]
32. Cockayne's syndrome fibroblasts are characterized by hypersensitivity to deoxyguanosine and abnormal DNA precursor pool metabolism in response to deoxyguanosine or ultraviolet light. Squires S; Oates DJ; Bouffler SD; Johnson RT Somat Cell Mol Genet; 1992 Sep; 18(5):387-401. PubMed ID: 1475705 [TBL] [Abstract][Full Text] [Related]
33. Effect of 9-benzyl-9-deazaguanine, a potent inhibitor of purine nucleoside phosphorylase, on the cytotoxicity and metabolism of 6-thio-2'-deoxyguanosine. Parker WB; Allan PW; Niwas S; Montgomery JA; Bennett LL Cancer Res; 1994 Apr; 54(7):1742-5. PubMed ID: 8137289 [TBL] [Abstract][Full Text] [Related]
34. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation. Hershfield MS; Kredich NM Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019 [TBL] [Abstract][Full Text] [Related]
35. A purine nucleoside phosphorylase (PNP) inhibitor induces apoptosis via caspase-3-like protease activity in MOLT-4 T cells. Posmantur R; Wang KK; Nath R; Gilbertsen RB Immunopharmacology; 1997 Oct; 37(2-3):231-44. PubMed ID: 9403342 [TBL] [Abstract][Full Text] [Related]
36. Purine deoxyribonucleosides counteract effects of hydroxyurea on deoxyribonucleoside triphosphate pools and DNA synthesis. Lagergren J; Reichard P Biochem Pharmacol; 1987 Sep; 36(18):2985-91. PubMed ID: 3498491 [TBL] [Abstract][Full Text] [Related]
37. Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes. Kicska GA; Long L; Hörig H; Fairchild C; Tyler PC; Furneaux RH; Schramm VL; Kaufman HL Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4593-8. PubMed ID: 11287638 [TBL] [Abstract][Full Text] [Related]
38. Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells. Cohen A; Lee JW; Gelfand EW Blood; 1983 Apr; 61(4):660-6. PubMed ID: 6600944 [TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency. North ME; Newton CA; Webster AD Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354 [TBL] [Abstract][Full Text] [Related]
40. Differential metabolism of guanine nucleosides by human lymphoid cell lines. Mitchell BS; Sidi Y Proc Soc Exp Biol Med; 1985 Sep; 179(4):427-31. PubMed ID: 3875100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]